SC
CLX icon

Savant Capital’s Clorox CLX Stock Holding History

Savant Capital’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$355K Sell
3,667
-188
-5% -$18K ﹤0.01% 1407
2026
Q1 		$399K Buy
3,855
+525
+16% +$59.5K ﹤0.01% 1025
2025
Q4 		$336K Sell
3,330
-868
-21% -$94.2K ﹤0.01% 998
2025
Q3 		$518K Sell
4,198
-345
-8% -$42.8K ﹤0.01% 784
2025
Q2 		$546K Buy
4,543
+427
+10% +$57K ﹤0.01% 716
2025
Q1 		$606K Sell
4,116
-517
-11% -$78.9K 0.01% 619
2024
Q4 		$752K Sell
4,633
-1,058
-19% -$173K 0.01% 757
2024
Q3 		$927K Buy
5,691
+2,376
+72% +$352K 0.01% 672
2024
Q2 		$452K Sell
3,315
-3,997
-55% -$555K ﹤0.01% 826
2024
Q1 		$1.12M Buy
7,312
+4,915
+205% +$734K 0.01% 506
2023
Q4 		$342K Sell
2,397
-105
-4% -$14K ﹤0.01% 665
2023
Q3 		$328K Buy
2,502
+57
+2% +$8.66K ﹤0.01% 630
2023
Q2 		$389K Buy
2,445
+33
+1% +$5.32K 0.01% 576
2023
Q1 		$382K Buy
2,412
+513
+27% +$76.9K 0.01% 532
2022
Q4 		$262K Buy
1,899
+251
+15% +$35.6K 0.01% 500
2022
Q3 		$212K Buy
1,648
+67
+4% +$9.67K 0.01% 499
2022
Q2 		$223K Sell
1,581
-158
-9% -$22.6K 0.01% 506
2022
Q1 		$243K Buy
1,739
+253
+17% +$38.8K 0.01% 504
2021
Q4 		$259K Buy
1,486
+232
+19% +$38.7K 0.01% 478
2021
Q3 		$208K Sell
1,254
-29
-2% -$4.99K 0.01% 496
2021
Q2 		$231K Sell
1,283
-133
-9% -$24.3K 0.01% 450
2021
Q1 		$273K Buy
1,416
+105
+8% +$20.2K 0.01% 393
2020
Q4 		$265K Sell
1,311
-381
-23% -$78.8K 0.02% 379
2020
Q3 		$356K Sell
1,692
-49
-3% -$10.9K 0.02% 303
2020
Q2 		$382K Buy
1,741
+72
+4% +$14.4K 0.03% 285
2020
Q1 		$289K Sell
1,669
-275
-14% -$45.4K 0.03% 297
2019
Q4 		$298K Buy
1,944
+53
+3% +$7.92K 0.04% 282
2019
Q3 		$287K Sell
1,891
-10
-0.5% -$1.58K 0.04% 269
2019
Q2 		$291K Sell
1,901
-30
-2% -$4.58K 0.04% 266
2019
Q1 		$310K Buy
1,931
+105
+6% +$16.3K 0.06% 215
2018
Q4 		$281K Sell
1,826
-24
-1% -$3.74K 0.06% 213
2018
Q3 		$278K Buy
1,850
+24
+1% +$3.41K 0.05% 238
2018
Q2 		$247K Sell
1,826
-100
-5% -$12.3K 0.05% 243
2018
Q1 		$256K Buy
1,926
+50
+3% +$6.72K 0.05% 238
2017
Q4 		$279K Buy
1,876
+45
+2% +$6.12K 0.06% 230
2017
Q3 		$242K Buy
1,831
+30
+2% +$4.03K 0.05% 240
2017
Q2 		$240K Hold
1,801
– – 0.06% 233
2017
Q1 		$243K Buy
1,801
+60
+3% +$7.77K 0.06% 229
2016
Q4 		$209K Hold
1,741
– – 0.06% 242
2016
Q3 		$218K Sell
1,741
-810
-32% -$106K 0.06% 229
2016
Q2 		$353K Buy
2,551
+80
+3% +$10.4K 0.1% 158
2016
Q1 		$311K Buy
2,471
+30
+1% +$3.81K 0.09% 161
2015
Q4 		$310K Hold
2,441
– – 0.1% 160
2015
Q3 		$282K Hold
2,441
– – 0.1% 163
2015
Q2 		$254K Hold
2,441
– – 0.09% 188
2015
Q1 		$269K Buy
2,441
+10
+0.4% +$1.09K 0.1% 173
2014
Q4 		$253K Buy
+2,431
New +$243K 0.1% 179

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Savant Capital's CLX Position: Q2 2026 in Review

Savant Capital reduced its Clorox (CLX) stake by 4.9% in Q2 2026, selling an estimated $18K and leaving 3,667 shares worth $355K. The position accounts for ﹤0.01% of the portfolio, ranked #1407.

Savant Capital first reported a position in CLX in Q4 2014 and has held it in 47 quarters since. The position peaked at $1.12M in Q1 2024. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Savant Capital held 3,667 shares of Clorox worth $355K as of Q2 2026.
  • Savant Capital sold 188 Clorox shares in Q2 2026, an estimated $18K.
  • Clorox made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #1407 holding.
  • Savant Capital first reported a position in Clorox in Q4 2014 and has held it in 47 quarters since.
  • Savant Capital's Clorox position peaked at $1.12M in Q1 2024.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.